Notes to SEFA
Title: Assistance Listing Numbers (ALN)
Accounting Policies: Expenditures reported in the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures may or may not be allowable or may be limited as to reimbursement.
De Minimis Rate Used: N
Rate Explanation: 0
The ALN included in the Schedule are determined based on the program name, review of grant contract information, and the public descriptions of Federal Assistance Listing published by the U.S. Government.
Title: Major federal program
Accounting Policies: Expenditures reported in the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures may or may not be allowable or may be limited as to reimbursement.
De Minimis Rate Used: N
Rate Explanation: 0
The major federal program is identified in the Summary of Auditors’ Results Section in the Schedule of Findings and Questioned Costs. The Federal program is presented by federal agency.
Title: Provider Relief fund
Accounting Policies: Expenditures reported in the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures may or may not be allowable or may be limited as to reimbursement.
De Minimis Rate Used: N
Rate Explanation: 0
During the year ended June 30, 2022, the Company received grants under the Provider Relief Fund (PRF) amounting to $1,328,219. The PRF is administered by the Health Resources and Services Administration (HRSA) and provides relief funds to hospitals and other healthcare providers involved in the COVID-19 response. The funding supports healthcare related expenses or lost revenue attributable to COVID-19. As provided by the 2022 OMB Compliance Supplement (the 2022 Compliance Supplement), due to delays in the launch of HRSA’s PRF reporting portal, PRF funds received during the year ended June 30, 2022 were to be excluded from the schedule of expenditures of federal awards for the year then ended and, instead, included in the schedule of expenditures of federal awards for the year ended June 30, 2023. As such, the Schedule includes the PRF funds received and expended by the Company during the year ended June 30, 2022 amounting to $1,328,219.